Literature DB >> 10585760

Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.

P H King1, D Redden, J S Palmgren, L B Nabors, V A Lennon.   

Abstract

Despite a broad clinical spectrum, paraneoplastic enecephalomyelitis/sensory neuronopathy (PEM/SSN) is characterized by the presence of a common autoantibody, referred to as anti-Hu or type I anti-neuronal nuclear antibody (ANNA-1). The target of these antibodies is a family of four Hu antigens: three (Hel-N1, HuC, HuD) are neural-specific, while the fourth (HuR) is ubiquitous. Here, we have analysed by enzyme-linked immunosorbent assay (ELISA) the immunoreactivity of all four Hu antigens in serum from 75 patients with ANNA-1 autoantibodies and looked for clinical correlations. IgG in all the patients' sera bound to each of the four antigens, and the titers correlated with those of the ANNA-I immunofluorescence assay. Median titers for the neural-specific antigens (range: 56, 892-90,051) were significantly higher than for HuR (36,799). Patients with gastrointestinal dysmotility or subacute sensory neuronopathy had the highest median titers to all four antigens, while patients with sensorineural deafness had the lowest titers. The results indicate a heterogeneous immune response to individual Hu antigens in patients with PEM/SSN, and that the titers to these antigens as a group, rather than individually, correlate with clinical profile. Furthermore, these results suggest that ELISA analysis of a single neural-specific Hu antigen is sufficient for serological screening in PEM/SSN. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585760     DOI: 10.1006/jaut.1999.0337

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  26 in total

Review 1.  Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction.

Authors:  R De Giorgio; G Sarnelli; R Corinaldesi; V Stanghellini
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

2.  Acute on chronic intestinal pseudo-obstruction as a cause of death in a previously healthy twenty-year-old male.

Authors:  Joshua T Evans; Mark H Delegge; Christopher Lawrence; David Lewin
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 3.  Chronic intestinal pseudo-obstruction.

Authors:  Alexandra Antonucci; Lucia Fronzoni; Laura Cogliandro; Rosanna-F Cogliandro; Carla Caputo; Roberto De Giorgio; Francesca Pallotti; Giovanni Barbara; Roberto Corinaldesi; Vincenzo Stanghellini
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

4.  Migration pathways of sacral neural crest during development of lower urogenital tract innervation.

Authors:  Carrie B Wiese; Karen K Deal; Sara J Ireland; V Ashley Cantrell; E Michelle Southard-Smith
Journal:  Dev Biol       Date:  2017-04-25       Impact factor: 3.582

5.  Enteric Nervous System: Neuropathic Gastrointestinal Motility.

Authors:  Jackie D Wood
Journal:  Dig Dis Sci       Date:  2016-07       Impact factor: 3.199

Review 6.  Clinical significance of HuR expression in human malignancy.

Authors:  Ioly Kotta-Loizou; Constantinos Giaginis; Stamatios Theocharis
Journal:  Med Oncol       Date:  2014-08-13       Impact factor: 3.064

7.  Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.

Authors:  D A Dixon; N D Tolley; P H King; L B Nabors; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

8.  Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression.

Authors:  Narek Israelyan; Andrew Del Colle; Zhishan Li; Yeji Park; Albert Xing; Jacob P R Jacobsen; Ruth Ann Luna; Dane D Jensen; Moneek Madra; Virginia Saurman; Ray Rahim; Rocco Latorre; Kimberly Law; William Carson; Nigel W Bunnett; Marc G Caron; Kara G Margolis
Journal:  Gastroenterology       Date:  2019-05-07       Impact factor: 22.682

9.  Distribution of TMEM100 in the mouse and human gastrointestinal tract--a novel marker of enteric nerves.

Authors:  S T Eisenman; S J Gibbons; R D Singh; C E Bernard; J Wu; M G Sarr; M L Kendrick; D W Larson; E J Dozois; K R Shen; G Farrugia
Journal:  Neuroscience       Date:  2013-02-26       Impact factor: 3.590

10.  Neurogenic chronic intestinal pseudo-obstruction: antineuronal antibody-mediated activation of autophagy via Fas.

Authors:  Roberto de Giorgio; Umberto Volta; Vincenzo Stanghellini; Rosanna F Cogliandro; Giovanni Barbara; Roberto Corinaldesi; Roberto Towns; Chunfang Guo; Shuangsong Hong; John W Wiley
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.